Statistics list in Clinical Diagnostics

U.S. confirmatory tests prostate cancer diagnostics market, 2016-2028 (USD Million)

U.S. confirmatory tests prostate cancer diagnostics market, 2016-2028 (USD Million)

The U.S. confirmatory tests prostate cancer diagnostics market size was valued at USD 241.3 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.9% from 2021 to 2028. Read More »

U.S. preliminary tests prostate cancer diagnostics market, 2016-2028 (USD Million)

U.S. preliminary tests prostate cancer diagnostics market, 2016-2028 (USD Million)

The U.S. preliminary tests prostate cancer diagnostics market size was valued at USD 771.9 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2021 to 2028. Read More »

U.S.  prostate cancer diagnostics market, 2016-2028 (USD Million)

U.S. prostate cancer diagnostics market, 2016-2028 (USD Million)

The U.S. prostate cancer diagnostics market size was valued at USD 1,013.2 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 12.3% from 2021 to 2028. Read More »

U.S. autoimmune disease chemiluminescence immunoassay market, 2016-2028 (USD Million)

U.S. autoimmune disease chemiluminescence immunoassay market, 2016-2028 (USD Million)

The U.S. autoimmune disease chemiluminescence immunoassay market size was valued at USD 406.7 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2021 to 2028. Read More »

U.S. endocrinology chemiluminescence immunoassay market, 2016-2028 (USD Million)

U.S. endocrinology chemiluminescence immunoassay market, 2016-2028 (USD Million)

The U.S. endocrinology chemiluminescence immunoassay market size was valued at USD 272.0 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.2% from 2021 to 2028. Read More »

U.S. oncology chemiluminescence immunoassay market, 2016-2028 (USD Million)

U.S. oncology chemiluminescence immunoassay market, 2016-2028 (USD Million)

The U.S. oncology chemiluminescence immunoassay market size was valued at USD 373.0 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.6% from 2021 to 2028. Read More »

U.S.  chemiluminescence immunoassay market, 2016-2028 (USD Million)

U.S. chemiluminescence immunoassay market, 2016-2028 (USD Million)

The U.S. chemiluminescence immunoassay market size was valued at USD 2,409.2 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2021 to 2028. Read More »

U.S. therapeutic drug monitoring chemiluminescence immunoassay market, 2016-2028 (USD Million)

U.S. therapeutic drug monitoring chemiluminescence immunoassay market, 2016-2028 (USD Million)

The U.S. therapeutic drug monitoring chemiluminescence immunoassay market size was valued at USD 208.3 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 3.7% from 2021 to 2028. Read More »

U.S. infectious disease testing chemiluminescence immunoassay market, 2016-2028 (USD Million)

U.S. infectious disease testing chemiluminescence immunoassay market, 2016-2028 (USD Million)

The U.S. infectious disease testing chemiluminescence immunoassay market size was valued at USD 664.5 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 8.0% from 2021 to 2028. Read More »

U.S. cardiology chemiluminescence immunoassay market, 2016-2028 (USD Million)

U.S. cardiology chemiluminescence immunoassay market, 2016-2028 (USD Million)

The U.S. cardiology chemiluminescence immunoassay market size was valued at USD 229.7 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 6.4% from 2021 to 2028. Read More »

Search Result of "Clinical Diagnostics"